Nervgen Pharma Corp Stock Probability of Future Stock Price Finishing Over 3.33
NervGen Pharma's future price is the expected price of NervGen Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of NervGen Pharma Corp performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please specify NervGen Pharma's target price for which you would like NervGen Pharma odds to be computed.
NervGen |
NervGen Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NervGen Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NervGen Pharma Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NervGen Pharma Corp is not yet fully synchronised with the market data | |
| NervGen Pharma Corp is way too risky over 90 days horizon | |
| NervGen Pharma Corp has some characteristics of a very speculative penny stock | |
| NervGen Pharma Corp appears to be risky and price may revert if volatility continues | |
| NervGen Pharma Corp has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (22.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NervGen Pharma Corp has accumulated about 8.27 M in cash with (11.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3. | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders |
NervGen Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NervGen Stock often depends not only on the future outlook of the current and potential NervGen Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NervGen Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.6 M |
NervGen Pharma Technical Analysis
NervGen Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. NervGen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NervGen Pharma Corp. In general, you should focus on analyzing NervGen Stock price patterns and their correlations with different microeconomic environments and drivers.
NervGen Pharma Predictive Forecast Models
NervGen Pharma's time-series forecasting models is one of many NervGen Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NervGen Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NervGen Pharma Corp
Checking the ongoing alerts about NervGen Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NervGen Pharma Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NervGen Pharma Corp is not yet fully synchronised with the market data | |
| NervGen Pharma Corp is way too risky over 90 days horizon | |
| NervGen Pharma Corp has some characteristics of a very speculative penny stock | |
| NervGen Pharma Corp appears to be risky and price may revert if volatility continues | |
| NervGen Pharma Corp has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (22.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NervGen Pharma Corp has accumulated about 8.27 M in cash with (11.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3. | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Tools for NervGen Stock
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |